The Transforming Growth Factor-β Pathway is a Common Target of Drugs that Prevent Experimental Diabetic Retinopathy

DSpace/Manakin Repository

The Transforming Growth Factor-β Pathway is a Common Target of Drugs that Prevent Experimental Diabetic Retinopathy

Citable link to this page

. . . . . .

Title: The Transforming Growth Factor-β Pathway is a Common Target of Drugs that Prevent Experimental Diabetic Retinopathy
Author: Gerhardinger, Chiara; Dagher, Zeina; Sebastiani, Paola; Park, Yong Seek; Lorenzi, Mara

Note: Order does not necessarily reflect citation order of authors.

Citation: Gerhardinger, Chiara, Zeina Dagher, Paola Sebastiani, Yong Seek Park, and Mara Lorenzi. 2009. The transforming growth factor-β pathway is a common target of drugs that prevent experimental diabetic retinopathy. Diabetes 58(7): 1659-1667.
Full Text & Related Files:
Abstract: OBJECTIVE-- Prevention of diabetic retinopathy would benefit from availability of drugs that preempt the effects of hyperglycemia on retinal vessels. We aimed to identify candidate drug targets by investigating the molecular effects of drugs that prevent retinal capillary demise in the diabetic rat. RESEARCH DESIGN AND METHODS-- We examined the gene expression profile of retinal vessels isolated from rats with 6 months of streptozotocin-induced diabetes and compared it with that of control rats. We then tested whether the aldose reductase inhibitor sorbinil and aspirin, which have different mechanisms of action, prevented common molecular abnormalities induced by diabetes. The Affymetrix GeneChip Rat Genome 230 2.0 array was complemented by real-time RT-PCR, immunoblotting, and immunohistochemistry. RESULTS-- The retinal vessels of diabetic rats showed differential expression of 20 genes of the transforming growth factor (TGF)-β pathway, in addition to genes involved in oxidative stress, inflammation, vascular remodeling, and apoptosis. The complete loop of TGF-β signaling, including Smad2 phosphorylation, was enhanced in the retinal vessels, but not in the neural retina. Sorbinil normalized the expression of 71% of the genes related to oxidative stress and 62% of those related to inflammation. Aspirin had minimal or no effect on these two categories. The two drugs were instead concordant in reducing the upregulation of genes of the TGF-β pathway (55% for sorbinil and 40% for aspirin) and apoptosis (74 and 42%, respectively). CONCLUSIONS-- Oxidative and inflammatory stress is the distinct signature that the polyol pathway leaves on retinal vessels. TGF-β and apoptosis are, however, the ultimate targets to prevent the capillary demise in diabetic retinopathy.
Published Version: doi:10.2337/db08-1008
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699853/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4737043

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters